Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mitchell R Smith

Showing results (21-30 of 129) with videos related to

Pageof 13
Sort By:
Expert Opinion on Pharmacotherapy|June 9, 2023
Is there a pathway for phosphatidylinositol 3-kinase delta inhibitors to be approved therapeutics for B-cell lymphoma therapyEfrat Luttwak, Mitchell R Smith, Andrew D Zelenetz
Clinical Advances in Hematology & Oncology : H&O|March 11, 2009
Review: lymphomatoid granulomatosis: challenges in diagnosis and treatmentElena Gitelson, Tahseen Al-Saleem, Mitchell R Smith
Discoveries (Craiova, Romania)|August 18, 2015
New agents for the treatment of lymphoid leukemia and lymphoma: focus on recent FDA approvalsAndreea Lucia Stancu, Mitchell R Smith, Alexandru Almasan
European Journal of Pharmacology|October 20, 2009
Immunotherapy of cancerHossein Borghaei, Mitchell R Smith, Kerry S Campbell
Stem Cells and Cloning : Advances and Applications|November 8, 2013
Tackling mantle cell lymphoma (MCL): Potential benefit of allogeneic stem cell transplantationSatish Shanbhag, Mitchell R Smith, Robert Vb Emmons
Clinical Lymphoma, Myeloma & Leukemia|February 19, 2025
Follicular Lymphoma: Paving the Path to Cures Through PhilanthropyMitchell R Smith, Michel Azoulay, Lee M Greenberger
Diagnostic Cytopathology|May 4, 2021
Crystal-storing histiocytes in ascites leading to a diagnosis of plasma cell myelomaFatima Hamadeh, Mitchell R Smith, Eric D Hsi
Academic Radiology|April 28, 2004
Predicting treatment response in non-Hodgkin's lymphoma from the pretreatment tumor content of phosphoethanolamine plus phosphocholineFernando Arias-Mendoza, Mitchell R Smith, Truman R Brown
Medicine and Science in Sports and Exercise|December 11, 2014
Mental Fatigue Impairs Intermittent Running PerformanceMitchell R Smith, Samuele M Marcora, Aaron J Coutts
Leukemia & Lymphoma|April 11, 2014
Complete remission of CD30-positive diffuse large B-cell lymphoma in a patient with post-transplant lymphoproliferative disorder and end-stage renal disease treated with single-agent brentuximab vedotinBrian T Hill, Raymond R Tubbs, Mitchell R Smith
Pageof 13

Showing results (21-30 of 129) with videos related to

Sort By:
Pageof 13
Expert Opinion on Pharmacotherapy|June 9, 2023
Is there a pathway for phosphatidylinositol 3-kinase delta inhibitors to be approved therapeutics for B-cell lymphoma therapyEfrat Luttwak, Mitchell R Smith, Andrew D Zelenetz
Clinical Advances in Hematology & Oncology : H&O|March 11, 2009
Review: lymphomatoid granulomatosis: challenges in diagnosis and treatmentElena Gitelson, Tahseen Al-Saleem, Mitchell R Smith
Discoveries (Craiova, Romania)|August 18, 2015
New agents for the treatment of lymphoid leukemia and lymphoma: focus on recent FDA approvalsAndreea Lucia Stancu, Mitchell R Smith, Alexandru Almasan
European Journal of Pharmacology|October 20, 2009
Immunotherapy of cancerHossein Borghaei, Mitchell R Smith, Kerry S Campbell
Stem Cells and Cloning : Advances and Applications|November 8, 2013
Tackling mantle cell lymphoma (MCL): Potential benefit of allogeneic stem cell transplantationSatish Shanbhag, Mitchell R Smith, Robert Vb Emmons
Clinical Lymphoma, Myeloma & Leukemia|February 19, 2025
Follicular Lymphoma: Paving the Path to Cures Through PhilanthropyMitchell R Smith, Michel Azoulay, Lee M Greenberger
Diagnostic Cytopathology|May 4, 2021
Crystal-storing histiocytes in ascites leading to a diagnosis of plasma cell myelomaFatima Hamadeh, Mitchell R Smith, Eric D Hsi
Academic Radiology|April 28, 2004
Predicting treatment response in non-Hodgkin's lymphoma from the pretreatment tumor content of phosphoethanolamine plus phosphocholineFernando Arias-Mendoza, Mitchell R Smith, Truman R Brown
Medicine and Science in Sports and Exercise|December 11, 2014
Mental Fatigue Impairs Intermittent Running PerformanceMitchell R Smith, Samuele M Marcora, Aaron J Coutts
Leukemia & Lymphoma|April 11, 2014
Complete remission of CD30-positive diffuse large B-cell lymphoma in a patient with post-transplant lymphoproliferative disorder and end-stage renal disease treated with single-agent brentuximab vedotinBrian T Hill, Raymond R Tubbs, Mitchell R Smith
Pageof 13